A fluorogenic probe for screening aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors

Area of Science:

• Biochemistry
• Enzyme Inhibition
• Drug Discovery

Background:

• Aldehyde dehydrogenase 1A1 (ALDH1A1) is a key enzyme in various biological processes.
• Developing selective ALDH1A1 inhibitors is crucial for therapeutic applications.
• Current screening methods for ALDH1A1 inhibitors can be limited in efficiency and cellular applicability.

Purpose of the Study:

• To report the development of the first competitive ALDH1A1 inhibitor with a fluorogenic binding response.
• To establish a novel method for real-time screening of non-fluorescent ALDH1A1 inhibitors.
• To assess the cellular compatibility and toxicity of the developed inhibitor.

Main Methods:

• Design and synthesis of a novel fluorogenic ALDH1A1 inhibitor.
• Characterization of inhibitor binding affinity using nanomolar K_D measurements.
• Evaluation of inhibitor performance in real-time screening assays with non-fluorescent compounds.
• Assessment of cellular compatibility and toxicity in relevant cell models.

Main Results:

• The developed inhibitor exhibits a competitive binding mechanism against ALDH1A1.
• The inhibitor displays nanomolar affinity (K_D) for ALDH1A1.
• The fluorogenic response enables efficient real-time screening of non-fluorescent inhibitors.
• High cellular compatibility and no observed toxicity were demonstrated.

Conclusions:

• A novel fluorogenic ALDH1A1 inhibitor has been successfully developed.
• This inhibitor provides a powerful tool for high-throughput screening of potential drug candidates.
• The developed assay offers a sensitive, cell-compatible, and non-toxic method for ALDH1A1 inhibitor discovery.